Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: A randomized, phase IV study.

MLA

Ilany, Jacob, et al. “Effect of Prandial Treatment Timing Adjustment, Based on Continuous Glucose Monitoring, in Patients with Type 2 Diabetes Uncontrolled with Once-Daily Basal Insulin: A Randomized, Phase IV Study.” Diabetes, Obesity & Metabolism, vol. 20, no. 5, May 2018, pp. 1186–92. EBSCOhost, https://doi.org/10.1111/dom.13214.

APA

Ilany, J., Bhandari, H., Nabriski, D., Toledano, Y., Konvalina, N., & Cohen, O. (2018). Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: A randomized, phase IV study. Diabetes, Obesity & Metabolism, 20(5), 1186–1192. https://doi.org/10.1111/dom.13214

Chicago

Ilany, Jacob, Hamad Bhandari, Dan Nabriski, Yoel Toledano, Noa Konvalina, and Ohad Cohen. 2018. “Effect of Prandial Treatment Timing Adjustment, Based on Continuous Glucose Monitoring, in Patients with Type 2 Diabetes Uncontrolled with Once-Daily Basal Insulin: A Randomized, Phase IV Study.” Diabetes, Obesity & Metabolism 20 (5): 1186–92. doi:10.1111/dom.13214.